Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna’s Massachusetts Facility – Merck & Co (NYSE:MRK), Moderna (NASDAQ:MRNA)
The U.S. Food and Drug Administration (FDA) identified several quality control issues at the primary manufacturing facility of Moderna Inc. MRNA during a September inspection. This revelation comes from a report obtained through…